Safety and efficacy of Immune checkpoint Inhibitors (ICIs) plus chemotherapy versus chemotherapy alone for small cell lung cancer (SCLC): A systematic review and meta-analysis of randomized controlled trials

被引：0
|
作者：
Mu, Xiaohong [1 ]
Wang, Yunfang [2 ]
Fan, Zhengye [3 ]
Yi, Kang [2 ]
机构：
[1] Huanxian Peoples Hosp, Dept Cardiovasc Med, Qingyang 745700, Peoples R China
[2] Gansu Prov Hosp, Lanzhou 730000, Peoples R China
[3] First Hosp Longnan City, Longnan 742500, Peoples R China
来源：
ASIAN JOURNAL OF SURGERY | 2025年 / 48卷 / 01期
关键词：
ETOPOSIDE;
D O I：
10.1016/j.asjsur.2024.07.155
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：805 / 806
页数：2
相关论文
共 50 条
  • [21] The efficacy and safety of immune checkpoint inhibitor plus chemotherapy in patients with advanced non-small-cell lung cancer: a meta-analysis
    Meng, Li-Fang
    Huang, Jian-Feng
    Luo, Peng-Hui
    Huang, Shang-Xiao
    Wang, Han-Lei
    INVESTIGATIONAL NEW DRUGS, 2022, 40 (04) : 810 - 817
  • [22] The efficacy and safety of immune checkpoint inhibitor plus chemotherapy in patients with advanced non-small-cell lung cancer: a meta-analysis
    Li-Fang Meng
    Jian-Feng Huang
    Peng-Hui Luo
    Shang-Xiao Huang
    Han-Lei Wang
    Investigational New Drugs, 2022, 40 : 810 - 817
  • [23] The landscape of immune checkpoint inhibitor plus chemotherapy versus immunotherapy for advanced non-small-cell lung cancer: A systematic review and meta-analysis
    Wang, Chengdi
    Qiao, Wenliang
    Jiang, Yuting
    Zhu, Min
    Shao, Jun
    Wang, Tao
    Liu, Dan
    Li, Weimin
    JOURNAL OF CELLULAR PHYSIOLOGY, 2020, 235 (05) : 4913 - 4927
  • [24] Comparing strategy of immune checkpoint inhibitors plus chemotherapy with chemotherapy alone for small cell lung cancer: a meta-analysis based on six RCTs incorporating 2800 participants
    Yaqi Zhong
    Qing Wu
    Sumei Wu
    Xianhe Xie
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 2465 - 2474
  • [25] Comparing strategy of immune checkpoint inhibitors plus chemotherapy with chemotherapy alone for small cell lung cancer: a meta-analysis based on six RCTs incorporating 2800 participants
    Zhong, Yaqi
    Wu, Qing
    Wu, Sumei
    Xie, Xianhe
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (09) : 2465 - 2474
  • [26] The predictive efficacy of tumor mutational burden for Immune Checkpoint Inhibitors in non-small cell lung cancer: A systematic review and meta-analysis of randomized controlled trials
    Ying, M.
    Hu, M.
    Lei, Q.
    Weng, K.
    Zhou, W.
    ANNALS OF ONCOLOGY, 2024, 35
  • [27] Efficacy and safety of immune checkpoint inhibitors (ICIs) in unresectable hepatocellular carcinoma (HCC): A systematic review and meta-analysis of randomized clinical trials (RCTs).
    Jacome, Alexandre A.
    Guimaraes De Castro, Ana Carolina
    Solar Vasconcelos, Joao Paulo
    Cruz Rangel Silva, Maria Helena
    Oliveira Lessa, Marco Antonio
    de Moraes, Eduardo Dias
    Andrade, Aline Chaves
    Figueiredo Ferreira, Barbara Sodre
    Lima, Frederico M. T.
    Bulcao, Marcela Lima
    Ferreira, Artur Rodrigues
    Fogacci De Farias, Joao Paulo
    Prolla, Gabriel
    Garicochea, Bernardo
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [28] Safety and efficacy of retreatment with immune checkpoint inhibitors in non-small cell lung cancer: a systematic review and meta-analysis
    Cai, Zijing
    Zhan, Ping
    Song, Yong
    Liu, Hongbing
    Lv, Tangfeng
    TRANSLATIONAL LUNG CANCER RESEARCH, 2022, : 1555 - 1566
  • [29] Efficacy and safety of immune checkpoint inhibitors as neoadjuvant therapy in perioperative patients with non-small cell lung cancer: a network meta-analysis and systematic review based on randomized controlled trials
    Chen, Kaiqi
    Wang, Xinwei
    Yue, Rui
    Chen, Wei
    Zhu, Danping
    Cui, Shikui
    Zhang, Xijian
    Jin, Zhao
    Xiao, Tong
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [30] Immune checkpoint inhibitors plus chemotherapy versus chemotherapy alone as first-line therapy for advanced gastric and esophageal cancers: A systematic review and meta-analysis
    Noori, Maryam
    Mahjoubfar, Aref
    Azizi, Shadi
    Fayyaz, Farimah
    Rezaei, Nima
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 113
12345